Product
RiMO-401
Aliases
Radiation
1 clinical trial
2 indications
Indication
Advanced Solid TumorIndication
Intratumoral InjectionClinical trial
Phase I Dose-Escalation Study of RiMO-401 With Radiation in Advanced TumorsStatus: Recruiting, Estimated PCD: 2026-01-01